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step of organic nitrogen mineralization to produce 
ammonia and carbamate. The carbamate produced dur-
ing this reaction spontaneously decomposes, at physi-
ological pH, to give a second molecule of ammonia 
and bicarbonate [3–6]. The hydrolysis of the reaction 
products causes an abrupt overall pH increase, the 
major cause for the negative side effects of the action 
of urease both for human and animal health, and for 
agriculture. Urease inhibitors have also been proposed 
to control urea hydrolysis in soil [6–16]. In particular, 
compound with the P(X)–NH2 segment (X = O, S) 
have received considerable attention as urease inhibi-
tors. The most effective inhibitors are substituted both 
thiophosphinicamide and phosphinicamide families. 
Many phosphoramide compounds are the most effective 
compounds currently available to retard the hydrolysis 
of urea fertilizer in soil and to decrease ammonia vola-
tilization and nitrite accumulation in soils treated with 
urea. (Thio)phosphoramide inhibited urease by form-
ing a chelated complex with the nickel ion in the active 
site of enzyme. Phosphoramide acts as urease inhibi-
tors by coordinating itself to the nickel ions of active 
site [15]. The oxygen or sulfur atoms and amide group 
of the inhibitor molecule are engaged in the formation 
of a bridge between the Ni(1) and Ni(2) ions. In this 
work, we have compared the effectiveness of new (thio)
phosphorhydrazide compounds (1–17) to inhibit jack 
bean urease toward (thio)phosphoramides. In addition, 
we carried out quantitative structure–activity relation-
ship (QSAR) studies on the aforementioned derivatives 
to gain an understanding of the activity shown by such 
compounds, to propose its union mode to the urease 
active site, and to try to create the correlation between 
the electronic and structural parameters in contrast to 
the inhibition potency.
Abstract New phosphorhydrazide compounds (1–7, 13, 
15–16) and thiophosphorhydrazide (14 and 17) were syn-
thesized and characterized by 31P, 13C, 1H NMR and IR 
spectroscopy. Furthermore, the crystal structure of com-
pound (C6H5NH)(C6H5O)P(O)(NH–NH2) (2) was investi-
gated. The activities of derivatives on acetylcholinesterase 
(AChE) and urease were determined. Quantitative struc-
ture–activity relationship (QSAR) was used to understand 
the relationship between molecular structural features and 
inhibitory. DFT–QSAR models for enzymes demonstrated 
the importance of ELUMO parameter in describing the anti-
AChE and anti-urease activities of the synthesized com-
pounds. The correlation matrix of QSAR models and dock-
ing analysis confirmed that electrophilicity descriptor can 
control the influence of the polarizability properties of N–H 
functional group of PAH derivatives in the inhibition of 
enzymes.
Keywords Phosphorhydrazide · Crystal structure · 
Urease inhibitor · Anti-AChE · QSAR
Introduction
Urease catalyzes the hydrolysis of urea in plants, algae, 
fungi, and several microorganisms [1, 2], in the final 
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The enzyme AChE (human erythrocyte; Sigma, Cat. 
No. C0663) and BChE (bovine erythrocyte, Sigma, Cat. 
No. B4186), Triton X-100, bovine serum albumin, Ace-
tylcholinesterase (AChE, EC 3.1.1.7), alpha-naphthyl 
acetate, beta-naphthyl acetate, fast blue RR, DMSO, 
Sodium dodecyl sulfate (SDS) were all from Sigma-
Aldrich. Acetylthiocholine iodide (ATCh, 99 %, Fluka), 
5, 5′-dithiobis (2-nitrobenzoic acid)) (DTNB, 98 %, 
Merck), Na2HPO4, NaH2PO4 (99 %), (thio)hydrazide, 
triethylamine (99.5 %, Merck), CDCl3 (99 %, Sigma 
Aldrich), (C6H5O)P(O)Cl2 (99 %, Merck), (CH3O)2P(S)
Cl, (CH3CH2O)2P(S)Cl and (CH3CH2O)2P(O)Cl (97 %, 
Sigma Aldrich) were used as supplied. 1H, 13C, and 31P 
spectra were recorded on a Bruker Advance DRX 500 
spectrometer. 1H and 13C chemical shifts were deter-
mined relative to internal TMS, and 31P chemical shifts 
were determined relative to 85 % H3PO4 as the exter-
nal standard. Infrared (IR) spectra were recorded on a 
Shimadzu model IR-60 spectrometer using KBr pellets. 
Melting points of the compounds were obtained with an 
electrothermal instrument. UV spectrophotometer was 
operated using a PERKIN-ELMER Lambda 25. The cor-
relation analysis was performed by the Statistical Pack-
age for Social Scientists (SPSS), version 16.0 for Win-
dows [17].
Synthesis
The synthesis pathway of compounds 1–17 was repre-
sented in Scheme 1.
N‑Hydrazino diphenyl amidophosphate (1)
A solution of hydrazine hydrate (2 mmol) in THF was 
added at 0 °C to a solution of (C6H5O)2P(O)Cl (1 mmol) 
in THF. After 4 h stirring, the solvent was removed in 
vacuum and the resulting white powder was washed with 
distilled water. Powder sample; m.p. 92 °C, 1H NMR 
(300.13 MHz, d6–DMSO, 25 °C, TMS); δ = 7.38 (t, 4H), 
7.25 (d, 4H), 7.19 (t,2H), 6.87 (d,2JPNH = 38.4 Hz,1H, 
N–Hamid), 3.99 (2H, NH2) ppm. 
13C NMR (75.46 MHz, 
TMS); δ = 150.57 (d, 2JPC = 6.3 Hz, Cipso), 129.72 (s, 
Cmetha), 124.77 (s, Cpara), 120.50 (d,3JPC = 4.6 Hz, 
Cortho) ppm.
31P NMR (121.49 MHz, d6–DMSO, 25 °C, 
H3PO4 external), δ = 1.05(m) ppm. IR (KBr) υ˜ = 3327–
3211 (N–H), 1217 (P=O), 1071 (P–O), 934 (P–N), 905 
(N–N) cm−1.
N‑Hydrazino (O‑phenyl)(N‑phenyl) amidophosphate (2)
This compound was synthesized similar to the preparation 
method of compound 1 using of (C6H5O)P(O)(NHC6H5)
Cl [18] instead of (C6H5O)2P(O)Cl. Powder sample; m.p. 
229 °C, 1H NMR (500.13 MHz, d6–DMSO, 25 °C, TMS); 
δ = 6.46 (d, 2 H, 2JPNH = 32.6 Hz, NH–NH), 6.84 (t, 1 H, 
OC6H5), 7.14 (t, 1 H, HNC6H5), 7.20 (m, 2 H, HNC6H5), 
7.22 (d, 2 H, OC6H5), 7.33 (t, 2 H, OC6H5), 7.85 (d, 2 H, 
3JPNH = 8.5 Hz, NH) ppm. 13C NMR (125.75 MHz, d6–
DMSO, 25 °C, TMS); δ = 117.37 (d, 3JPC = 7.4 Hz, 2 
C, ortho-HNC6H5), 120.71 (d, 
3JPC = 4.5 Hz, 2 C, ortho-
OC6H5), 124.12 (s, 1 C, para-OC6H5), 128.03 (s, 1 C, 
para-HNC6H5), 129.39 (s, 2 C, meta-OC6H5), 135.94 (s, 2 
C, meta-HNC6H5), 143.80 (s, 1 C, ipso-HNC6H5), 150.90 
(d, 2JPC = 6.6 Hz, 1 C, ipso-OC6H5) ppm. 31P{1H} and 
31P NMR (202.45 MHz, d6–DMSO, 25 °C, H3PO4 exter-
nal); δ = −6.45 (s) (d, 2JPNH = 32.9 Hz) ppm. IR (KBr): 
υ˜ = 3225 (N–H), 3066 (N–H), 1605 (s), 1499 (s), 1219 
(P=O), 950 (P–O), 751 (P–N).
N,N′‑Di hydrazino phosphoramidic acid 4‑chloro phenyl 
ester (3)
A solution of hydrazine hydrate (4 mmol) in THF was 
added at 0 °C to a solution of (p-ClC6H5O)P(O)Cl2 
(1 mmol) in THF. After 4 h stirring, the solvent was 
removed in vacuum and the resulting white powder was 
washed with distilled water. Powder sample; m.p. 171 °C, 
1H NMR (300.13 MHz, d6–DMSO, 25 °C, TMS), δ = 7.32 
(d, 3JHH = 8.6 Hz, 2H, Ar–H), 7.15 (d, 3J HH = 9.0 Hz, 2H, 
Ar–H), 7.07 (d, 2JPNH = 31.0 Hz, 2H, NH), 5.66 (br, 4H, 
2NH2) ppm. 
13C NMR (75.47 MHz, d6–DMSO, 25 °C, 
TMS), δ = 151.21 (d, 2JPC = 6.2 Hz, Cipso), 128.84 (s), 
127.06 (s), 121.80 (d, 3JPC = 4.9 Hz, Cortho(ppm. 31P 
NMR (121.49 MHz, d6–DMSO, 25 °C, H3PO4 external), 
δppm = −5.44(m) ppm. IR (KBr) υ˜ = 3355–3207 (N–H), 
1210 (P=O), 979 (P–N), 924 (N–N) cm−1.
N,N′‑Di hydrazino phosphoramidic acid 4‑methyl phenyl 
ester (4)
This compound was synthesized similar to the prepara-
tion method of compound 3 using of (p-CH3C6H5O)P(O)
Cl2 instead of (p-ClC6H5O)P(O)Cl2. Powder sample; m.p. 
153 °C, 1H NMR (300.13 MHz, d6–CDCl3, 25 °C, TMS); 
δ = 6.98–7.06 (q, 4H, Ar–H), 6.01 (d, 2JPNH = 31.9 Hz, 
2H, 2NH), 5.84 (br, 4H, 2NH2), 2.26 (s, 3H, p-CH3) 
ppm. 13C NMR (75.46 MHz, DMSO, 25 °C, TMS); 
δ = 150.40 (d, 2JPC = 6.3 Hz, Cipso), 131.62 (s), 129.44 
(s), 119.80 (d, 3JPC = 4.8 Hz, Cortho), 20.26 (s) ppm. 31P 
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NMR (121.49 MHz, d6–DMSO, 25 °C, H3PO4 external), 
δ = −4.69(m) ppm. IR (KBr) υ˜ = 3300–3250 (N–H), 1214 
(P=O), 1034 (P–O), 979 (P–N), 922 (N–N) cm−1.
Chloro N‑(semicarbazido) phosphoramidic acid phenyl 
ester (5)
A solution of semicarbazide (1 mmol) and triethylamine 
(1 mmol) in THF was added at 0 °C to a solution of (C6H5O)
P(O)Cl2 (1 mmol) in THF. After 4 h stirring, the solvent was 
removed in vacuum and the resulting white powder was 
washed with distilled water. Powder sample; m.p. 152 °C. 
1H NMR (400 MHz, d6–DMSO, 25 °C, TMS); δ = 7.63 
(s,1H, N–Hamid), 7.45 (d, 
2JPNH = 35.6 Hz,1 H, N–HPNH), 
7.39–7.15 (5H, m, Ar–H), 5.85 (s,2H, N–Hamid) ppm. 
13C 
NMR (100.51 MHz, d6–DMSO, 25 °C, TMS); δ = 159.60 
(s, C=O), 151.20 (d, Cipso, 2JPC = 6.0 Hz); 130.00 (s, Cpara), 
125.05 (s, Cmetha), 120.82 (d, Cortho, 
3JPC = 5.0 Hz) ppm 
31P NMR (161.81 MHz, DMSO,25 °C, H3PO4external), 
δppm = 1.98 (d, 2JPNH = 34.8 Hz). IR (KBr) υ˜ = 3423–3234 
(N–H), 1665 (C=O), 1212 (P=O), 969 (P–N) cm−1.
Chloro N‑(semicarbazido) phosphoramidic acid 4‑chloro 
phenyl ester (6)
This compound was synthesized similar to the preparation 
method of compound 5 using of (p-CH3C6H5O)P(O)Cl2 
instead of (C6H5O)P(O)Cl2. Powder sample; m.p. 174 °C, 
1H NMR (300.13 MHz, d6–DMSO, 25 °C, TMS); δ = 7.64 
(s, 1 H, N–Hamid), 7.48 (d, 
2JPNH = 35.6 Hz, 1 H, N–HPNH), 
7.43–7.24 (4H, m, Ar–H), 5.84 (s, 2 H, NH2) ppm. 
13C 











R1 = OC6H5; R2 = Cl; R3 = NH2 (5)
R1 = Cl-OC6H4; R2 = Cl; R3 = NH2 (6)
R1 = C6H5; R2 = Cl; R3 = NH2 (7)
R1 = OC6H5; R2 =OC6H5; R3 = NH2 (8)
R1 = OC2H5; R2 =OC2H5; R3 = NH2 (9)























R1 & R2 = OC2H5; R3 = NH2 (10)









R1 & R2= OC6H5; R3 = H; X = O (1)
R1 = NH-C6H5; R2= OC6H5; R3 = H; X = O (2)
R1 = Cl-OC6H4; R2 = NH-NH2; R3 = H; X = O (3)
R1 = CH3-OC6H4; R2 = NH-NH2; R3 = H; X = O(4)
R1 = Cl-OC6H4; R2 = NH-NH-C6H5; R3 = C6H5; X = O (15)
R1 = CH3-OC6H4; R2 = NH-NH-C6H5; R3 = C6H5; X = O (16)


























Scheme 1  Preparation of PHA derivatives (1–17)
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(s, 1 C, C=O), 149.5 7 (d, Cipso,2JPC = 6.4 Hz).), 129.48 (s, 
Cpara), 128.63 (s, Cmetha), 122.23 (d,
3JPC = 4.7 Hz, Cortho) 
ppm. 31P NMR (161.83 MHz, d6–DMSO, 25 °C, H3PO4 
external), δ = 2.08 (d,2JPNH = 35.6 Hz) ppm. IR (KBr) 
υ˜ = 3420–3231 (N–H), 1664 (C=O), 1229 (P=O), 965 
(P–N) cm−1.
Chloro phenyl N‑(semicarbazido) phosphoramidic acid (7)
This compound was synthesized similar to the prepa-
ration method of compound 5 using of (C6H5)P(O)
Cl2 instead of (C6H5O)P(O)Cl2. Powder sample; m.p. 
199 °C, 1H NMR (300.13 MHz, d6–DMSO, 25 °C, TMS); 
δ = 7.78–7.40 (5H, m, Ar–H), 7.32 (s, 1 H, N–Hamid), 7.18 
(d, 2JPNH = 27.0 Hz, 1 H, N–HPNH), 5.79 (s, 2 H, NH2) 
ppm. 13C NMR (75.47 MHz, d6–DMSO, 25 °C, TMS); 
δ = 159.85 (s, C=O), 131.72 (d, Cipso, 1JPC = 16.6 Hz), 
131.50 (s, Cmetha), 129.13 (s, Cpara), 128.21 (d, Cortho, 
2JPC = 13.9 Hz) ppm. 31P NMR (121.49 MHz, d6–DMSO, 
25 °C, H3PO4 external); δ = 20.93 (d,2JPNH = 27.0 Hz) 
ppm.IR (KBr) υ˜ = 3412–3213 (N–H), 1662 (C=O), 1204 
(P=O), 973 (P–N)cm−1.
N,N′‑Bis(O,O‑diethyl phosphorothioyl)hydrazide (14)
A solution of hydrazine hydrate (3 mmol) in THF was 
added at 0 °C to a solution of (C2H5O)2P(O)Cl (2 mmol) in 
THF. After 4 h stirring, the solvent was removed in vacuum 
and the resulting white powder was washed with distilled 
water. Powder sample; m.p. 84 °C, 1H NMR (300.13 MHz, 
d6–DMSO, 25 °C, TMS), δ = 7.20 (d, 2JPNH = 38.1 Hz, 
2H, N–H), 4.0 (m, 8H, CH2), 1.20–1.25 (t, 
3JHH = 7.0 Hz, 
12H, CH3) ppm. 
13C NMR (75.46 MHz, d6–DMSO, 25 °C, 
TMS), δ = 62.29 (s, CH2), 15.72 (s, CH3) ppm. 31P NMR 
(121.49 MHz, d6–DMSO, 25 °C, H3PO4 external) ppm. 
δ = 70.90 (m). IR (KBr) υ˜ = 3390–3251 (N–H), 1024 
(P–O), 965 (P–N), 897 (N–N), 795 (P=S) cm−1.
N,N′‑bis(phenyl hydrazino) phosphoramidic acid 4‑chloro 
phenyl ester (15)
A solution of phenyl hydrazin (4 mmol) in THF was added 
at 0 °C to a solution of (p-ClC6H5O)P(O)Cl2 (1 mmol) 
in THF. After 4 h stirring, the solvent was removed in 
vacuum and the resulting white powder was washed 
with distilled water. Powder sample; m.p. 167 °C, 1H 
NMR (250.13 MHz, d6–D2O, 25 °C, TMS), δ = 7.36 
(m, 2 H, N–HPNH, 
2JPNH = 35.3 Hz), 7.17 (d,2H, N–H, 
3JPNH = 31.8 Hz), 7.13–7.07 (m, 10 H, Ar–H), 6.87–6.84 
(m, 4 H, Ar–H), ppm. 13C NMR (75.47 MHz, d6–DMSO, 
25 °C, TMS), δ = 150.60 (s, Cipsophenyl), 149.99 (s, Cipso 
amine), 129.20 (s, Cmetha), 128.45 (s, Cmetha amine), 127.94 (s, 
Cpara), 122.47 (d, Cpara amine), 118.31 (s, Cortho), 112.56 (d, 
3JPC = 4.0 Hz, Cortho amine) ppm. 31P NMR (101.25 MHz, 
d6–DMSO, 25 °C, H3PO4 external), δ = 11.46(dt) ppm. 
IR (KBr) υ˜ = 3318–3267 (N–H), 1211 (P=O), 936 (P–N) 
cm−1.
N,N′‑bis(phenyl hydrazino) phosphoramidic acid 4‑methyl 
phenyl ester (16)
This compound was synthesized similar to the prepara-
tion method of compound 15 using of (p-CH3C6H5O)P(O)
Cl2 instead of (p-ClC6H5O)P(O)Cl2. Powder sample; m.p. 
196 °C, 1H NMR (250.13 MHz, d6–DMSO, 25 °C, TMS); 
δ = 7.10 (m, 2JPNH = 34.0 Hz, 2 H, N–HPNH), 7.13–7.07 (8 
H, Ar–H), 7.09 (d, 3JPNH = 31.3 Hz, 2 H, N–H), 6.89–6.85 
(4H, Ar–H), 6.99–6.64 (2H, Ar–H), 2.28 (s, 3 H, p-CH3) 
ppm. 13C NMR (75.47 MHz, d6–DMSO, 25 °C, TMS); 
δ = 150.31 (d, 2JPC = 4. 5 Hz, Cipso phenyl), 149.11 (d, 
3JPC = 6.4 Hz, Cipso amine), 131.26 (s, Cmeta), 128.43 (s, Cme-
tha amine), 120.46 (s, Cpara amine), 118.128 (s, Cortho), 112.558 
(d, 4JPC = 4.2 Hz, Cortho amine), 20.289 (s, p-CH3) ppm. 31P 
NMR (101.25 MHz, d6–DMSO, 25 °C, H3PO4 external); 
δ = 11.28 (d, 2JPNH = 34.0 Hz). IR (KBr) υ˜ = 3302–3202 
(N–H), 1219 (P=O), 937 (P–N) cm−1.
Diethyl N‑(phenyl hydrazino) amidothiophosphate (17)
A solution of phenyl hydrazin (2 mmol) in THF was added 
at at the room temperature to a solution of (C2H5O)P(S)
Cl2 (1 mmol) in THF. After 4 h refluxing, the solvent was 
removed in vacuum and the resulting white powder was 
washed with distilled water. Powder sample; m.p. 73 °C, 
1H NMR (300.13 MHz, d6–DMSO, 25 °C, TMS), δ = 7.57 
(s, 1 H, N–H), 7.002 (d, 3JHH = 6.0 Hz, 1 H, N–H), 7.004–
6.69 (m, 5 H, Ar–H), 4.08–3.98 (m, 10 H, 2C2H5) ppm. 
13C 
NMR (75.46 MHz, d6–DMSO, 25 °C, TMS), δ = 149.73 
(m, Cipso amine), 128.47 (s, Cpara), 118.25 (d, 
4JPC = 5.1 Hz, 
Cortho), 112.32 (d, 
5JPC = 4.2 Hz, Cmeta), 62.45 (d, 
3JPC = 4.9 Hz, CCH3), ppm. 31P NMR (101.25 MHz, 
d6–DMSO, 25 °C, H3PO4 external), δ = 71.94 (m, 
2JPNH = 43.2 Hz) ppm. IR (KBr) υ˜ = 3307–2978 (N–H), 
802 (P=S), 959 (P–N) cm−1.
Crystal structure determination
X–Ray data of compound 2 were collected on a Bruker 
SMART 1000 CCD area detector with graphite mono-
chromated Mo-Kα radiation (λ = 0.71073 Å) and refined 
by full-matrix least-squares methods against F2 with 
SHELXL97 [19]. CCDC 1027079 contain the supplemen-
tary crystallographic data for compound 2. These data can 
be obtained free of charge via http://www.ccdc.cam.ac.uk/
conts/retrieving.html, or from the Cambridge Crystal-
lographic Data Centre, 12 Union Road, Cambridge CB2 
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1EZ, UK; fax: (+44) 1223-336-033; or e-mail: deposit@
ccdc.cam.ac.uk.
Human ChE assay
Human AChE activity measurements were performed 
essentially according to the method of Ellman [20]. The 
reaction was carried out at 37 °C in 70 mM phosphate 
buffer (Na2HPO4/NaH2PO4, pH 7.4) containing the AChE 
enzyme (10 µl volume, diluted 100 times in phosphate 
buffer, pH 7.4), DTNB (5,5′-dithiobis (2-nitrobenzoic 
acid)) (10−4 M concentration) and ATCh (1.35 × 10−4 M 
concentration). Each compound was dissolved in dime-
thyl sulfoxide (DMSO), and then added to buffer for 
in vitro cholinesterase assays. The highest concentra-
tion of DMSO used in the assays was 5 %. In independ-
ent experiments without the inhibitor, 5 % DMSO had no 
effect on the inducing activity of enzyme. The absorbance 
change at 37 °C was monitored with the spectrophotom-
eter at 412 nm for 3 min and three replicates were run in 
each experiment. In the absence of inhibitor, the absorb-
ance change was directly proportional to the enzyme level. 
The reaction mixtures for determination of IC50 values, the 
median inhibitory concentration, consisted DTNB solution, 
100 μl; inhibitor, x μl; acetylthiocholin idide (ATCh) solu-
tion, 40 μl; phosphate buffer (850-×) μl and hAChE solu-
tion, 10 μl.
Urease inhibitory activity
Antiurease inhibition activity was tested by reported pro-
tocol [21]. Urea has been determined by the direct method 
where urea condenses with diacetyl to form a chromagen 
and an indirect method where ammonia is measured as a 
product of urease action on urea. The liberated ammo-
nia has been measured using Nessler’s reagent and by the 
Berthelot reaction. Talke and Schubert introduced a totally 
enzymatic procedure in 1965 utilizing urease and Gluta-
mate Dehydrogenase. The present procedure is based on a 
modification of their method.
Urea is hydrolyzed by urease to produce ammonia 
and carbon dioxide. The liberated ammonia reacts with 
α-ketoglutarate in the presence of NADH to yield gluta-
mate. An equimolar quantity of NADH undergoes oxidation 
during the reaction resulting in a decrease in absorbance 
that is directly proportional to the urea nitrogen concentra-
tion in the sample. Concentrations of reagents are NADH 
0.3 mM, urease 1500 U/L, glutamate dehydrogenase 
Urea+ H2O→ 2NH3 + CO2
NH3 + α-Ketoglutarate+ NADH+ H
+
→ L-glutamate+ NAD+ + H2O
>1500 U/L, α-ketoglutarate 4.0 mM, buffer pH 8.2 ± 0.1 
and phosphoramidate inhibitors. The reconstituted reagent 
has a reagent blank absorbance less than 1.0 at 340 nm.
Statistical analysis for QSAR model
In order to identify the effect of physicochemical parameters 
on the AChE inhibition activity, QSAR studies were under-
taken using the approach described by Hansch and Fujita. 
The stepwise multiple linear regression procedure is a com-
mon method in QSAR studies for selection descriptors. The 
MLR method performed by the software package SPSS 16.0 
was used for selection of the descriptors. The electronic and 
structural descriptors are obtained by either the quantum 
chemical calculations, theoretical and experimental stud-
ies. The electronic descriptors include the energy of frontier 
orbital (EHOMO and ELUMO), electrophilicity (ω), polarizabil-
ity (PL, the charge difference between the atoms in func-
tional groups) and the net atomic charges (Q). Also hydro-
phobic coefficient (logP), dipole moment (μ) and molecular 
volume (Mv) are the structural descriptors. EHOMO, ELUMO, 
ω, P, Q, μ and Mv values are obtained from the DFT results. 
The logarithm of partition coefficient (logP) is measured 
by the shake–flask and theoretical methods. The toxici-
ties of phosphorhydrazide analogues are expressed in terms 
of p(IC50) or −log(IC50) as an anti-cholinesterase activity. 
The descriptor values were related with toxicity using MLR 
analysis. MLR of descriptors, selected for biological activity, 
gives rise to the problem of multicollinearity. This problem 
can be solved using the principal component analysis (PCA). 
These linear combinations form a new set of variables, 
namely principal components (PCs), which are mutually 
orthogonal. The first PC contains the largest variance and 
the second new variable contains the second largest variance, 
and so on. The variable selection in this PCA study was 
performed using the Fisher’s weights. The descriptors with 
higher correlation coefficient and lower correlation (|r| < 0.5) 
to p(IC50) were selected to carry out stepwise MLR analysis 
and to optimize the QSAR equation [22]. The stable geom-
etry structures of compounds were further fully optimized 
using the Density functional theory (DFT) at the B3LYP/6–
311+G** level of theory. Natural population analysis (NPA) 
was performed at the same level using the Reed and Wein-
hold scheme [23]. All quantum chemical calculations were 
carried out using the Gaussian 03 program package [24].
Results and discussion
Spectral study
Spectroscopy data and phosphorus–hydrogen (2JPNH) 
coupling constants and δ(31P) of compounds 1–17 are 
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summarized in Table 1. Phosphorus chemical shifts δ(31P) 
were observed in the range of −6.45 ppm (2) to 74.03 ppm 
(11). As 31P NMR spectra reveal the effect of X on δ(31P), 
in P=X moiety this comparison can be made that 10, 11, 
12, 14, 17 compounds consisting P=S moeity show a high 
upfield shift rather than the compounds with P=O moi-
ety. That is to say, the presence of a sulfur atom leads to 
the deshielding of phosphorus atom in these derivatives. 
31P NMR spectra designate different patterns, compounds 
1, 3, 4, 14 indicate singlet pattern, although the rest are 
appeared as doublets. This splitting pattern arises from 
the spin couplings between the phosphorus nucleus and 
NH protons, while a doublet of triplet appeared in com-
pound 15 is achieved from the spin couplings between the 
phosphorus nucleus and NH and one equivalent hydrogen 
atoms in amine (NH) group. The 2JPNHα was observed for 
all compounds. The comparison of the 2JPNHα values indi-
cate that the compounds with the P=S group (10, 11, 12, 
14, 17) have a larger coupling than molecules with P=O 
group. The greatest and lowest 2JPNHα values are observed 
for 17 (2JPNHα = 43.24 Hz) with the (S)P–NHα–βHN–P(S) 
skeleton and 1 (2JPNHα = 30.99 Hz) with the (O)P–NHα–
βHN skeleton. The analysis of the IR spectra indicates that 
the vibrational bands of compounds 1–17 appear in the 
range of 3300–3445 cm−1 for NH group also the funda-
mental υ(P=X) stretching modes observed in the range of 
790 cm−1 (P=S) to 1209 cm−1 (P=O).
Crystal structures
Colorless single crystal of compound 2 which is suitable 
for X-ray diffraction analysis was grown from a THF/Chl-
roform mixture after slow evaporation at room tempera-
ture. The crystal data of X-ray analysis is given in Table 2. 
Molecular structure is shown in Figs. 1 for compound 2. 
Compound 2 crystallize in the triclinic crystal system with 
space group P−1. The phosphorus atom has a slightly dis-
torted tetrahedral configuration in compound 2, that is, 
the surrounding angles around the P atom are in the range 
of 95.75(9)°–116.22(9)°. The P=O bond distance is in 2 
1.4812(15) Å. The P–Nα bond distance in 2 1.6423(18) Å 
is shorter than the single bond P–N distance of 1.77 Å. 
The N(3)–H(3NA)…O(1A), N(3)–H(3NA)…N(1), N(1)–
H(1N)…N(3A), N(2)–H(2N)…O(1), N(1A)–H(1NA)…
N(3), N(2A)–H(2NA)…O(1A) and N(3A)–H(3NC)…O(1) 
hydrogen bonds produce along a linear direction (Table 3; 
Fig. 2). The polymeric chains are formed by hydrogen 
bonds in the crystal lattice with cyclic R22(8) motifs [25] via 
N(2A)–H(2NA)…O(1A) [d = 2.864(2) Å] (Fig. 2). Three 
molecules linked in the crystal lattice with cyclic R32(9) 
motifs which the molecules are connected to each other 
via two N(2A)–H(2NA)…O(1A) [d = 2.864(2) Å], N(3)–
H(3NA)…O(1A) [d = 2.995(3) Å] and N(3)–H(3NA)…
O(2) (d = 3.438 Å) hydrogen bonds (Fig. 2). The asymmet-
ric unit is composed of two independent molecules (Fig. 3).
Table 1  Selected spectroscopic 





2JPNH(hydrazide) νP=X(O,S) νN–H References
1 −5.44 7.07 38.4 1209 3354/3207 a
2 −6.45 7.85 32.9 1218 3224 a
3 −4.69 6.01 31.0 1214 3300/3250 a
4 1.05 6.87 31.9 1217 3327/3210 a
5 1.98 7.45 35.6 1212 3423/3234 a
6 2.08 7.48 35.6 1228 3419/3231 a
7 2.10 7.41 27.0 1203 3412/3212 a
8 2.61 7.82 38.0 1215 3300 [27]
9 6.21 7.02 32.2 1216 3423 [27]
10 69.89 7.39 39.9 790 3445 [27]
11 74.03 7.48 41.2 814 3440 [27]
12 68.66 7.89 35.1 792 3168/3415 [27]
13 8.48 7.27 31.0 1226 3432 a
14 70.90 7.20 38.1 795 3390/3251 a
15 11.46 7.17 35.3 1210 3318 a
16 11.28 7.09 34.0 1218 3302 a
17 71.94 7.57 43.2 802 3307 a




To test the experimental anti-acetylcholinesteras (anti-
ChE) [22] activity of the synthesized titled compounds, 
we evaluated the inhibitory potential of titled compounds 
against AChE enzyme by Ellman assay [20]. The inhibitory 
ability of selected compounds against AChE were in 2.34 
(11) to 35.52 (12) mM (Table 4). The inhibitory of com-
pound 4 is higher than compound 3 with the (R–C6H4O)
(O)P–(NH–NH2)2 (R=CH3, Cl). Comparison of 9 with the 
(C2H5O)2(O)P–NH–HN–C(O)NH2 structure and 10 with 
the (C2H5O)2(S)P–NH–HN–C(O)NH2 structure revealed 
the inhibitory of P=O (9) > P=S (10) including NH–HN–
C(O)NH2 moiety.
Anti‑urease activity
Thirteen PAH 1 and 3–14 were evaluated for their inhibi-
tory activities against jack bean urease. Percent inhibition at 
a 1 mM concentration of compounds 1 and 3–14 was ini-
tially determined, and the results were reported in Table 4. 
Most of the phosphorhydrazides showed good inhibi-
tory activities, especially PAH 9 (IC50 = 1.208 mM) and 
11 (IC50 = 1.611 mM) exhibited potent in vitro inhibitory 
activities. In general, compounds 5–11 with one NH–HN–
C(O)NH2 group exhibited better inhibitory activities than 
compound 12. According to Table 4 data, compound 3 
exhibited better inhibitory activity than 4. Compounds 1, 3, 
and 4, the order of inhibitory activities showed the potency 
of 3 > 1 > 4. It was possibly due to the difference between 
the electro affinities of chlorine, methylen, and proton. 
Compound 3 with halogen atom in the benzene ring showed 
better inhibitory activity than those with methyl substitutes.






Crystal system, space group Triclinic, P-1
Unit cell dimensions
 a (Å) 9.6500(8)
 b (Å) 10.2212(9)
 c (Å) 13.6586(12)
 α (°) 97.589(2)
 β (°) 105.344(3)
 γ (°) 90.617(2)
 V (Å3) 1286.33(19)
Z, calculated density (Mg m−3) 4, 1.359
Absorption coefficient (mm−1) 0.212
F(000) 552
Crystal size (mm) 0.35 × 0.35 × 0.05
θ range for data collection (°) 2.01–29.00
Limiting indices −13 ≤ h ≤ 13,
−13 ≤ k ≤ 13,
−18 ≤ l ≤ 18
Reflections collected/unique 15,665/6783
[R(int) = 0.0281]
Completeness to theta 99.3 %
Absorption correction Semi-empirical from equivalents
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 6783/0/326
Goodness-of-fit on F2 1.008
Final R indices R1 = 0.0520, wR2 = 0.1508
R indices (all data) R1 = 0.0612, wR2 = 0.1583
Largest diff. peak and hole (e Å−3) 0.547 and −0.440
Fig. 1  ORTEP representation of compound 2




The docking data provides important basic information 
including the interaction model, the effective functional 
groups as well as the electronic and structural properties on 
the inhibition mechanism. These data can be guide to create 
and to develop of the QSAR models. So far, no model in 
literatures has been suggested to explain of the inhibition 
mechanism PHAs against urease and AChE enzymes. Here, 
we explain the inhibition mechanism of human AChE and 
urease by theoretical QSAR models. The electronic and 
structural descriptors were obtained by quantum chemical 
calculations (Table 5). The number of the independent vari-
ables is more than the tested compounds shown in Table 5. 
Therefore, PCA method was used to reduce the independ-
ent variables. The principal components (PCs) as a new set 
of variables (mutually orthogonal) were obtained by this 
method. The first PC contains the largest variance and the 
second PC contains the second largest variance [26]. The 
variable selection in PCA was performed using the Fisher’s 
weights approach and the results are summarized as the fol-
lowing Eqs. (1a, 1b):
The results showed the total variance of the first, sec-
ond and third factor PC as 39.2 and 24.8 %, respectively. 
Also, from the above equations, it was deduced that the 
electronic parameters (Q, P, EMO and ω) are predominated 
from those related to structural parameters (logP and μ). 
Consequently, these eleven descriptors with higher corre-
lation coefficient were selected to carry out the stepwise 
multiple linear regression (MLR) analysis, which led to an 
optimal QSAR equation based on the anti-AChE potency 
(Eq. 2):
(1a)
PC1 = −0.340QN(α) − 0.307QN(β) + 0.308PN–H(α)
+ 0.378PN–H(β) + 0.230EHOMO + 0.431ELUMO
− 0.419ω + 0.306µ+ 0.091 logP
(1b)
PC1 = −0.319QN(α) − 0.028QN(β) + 0.254PN–H(α)
+ 0.157PN–H(β) − 0.332EHOMO − 0.133ELUMO
+ 0.193ω − 0.270µ− 0.475 logP
Table 3  Hydrogen-bond distances (Å) and angles (°) for 2
Symmetry transformations used to generate equivalent atoms: 1  x, 
y, z; 2 −x + 1, −y + 1, −z + 1; 3 −x + 2, −y, −z + 1; 4 −x + 2, 
−y + 1, −z + 1; 5 x, y + 1, z
D–H…A d(D-H) d(H····A) < DHA d(D····A)
N(3)–H(3NA)…O(1A)1 0.93 2.11 158 2.995(3)
N(3)–H(3NA)…N(1)1 0.93 2.61 115 3.115(3)
N(1)–H(1N)…N(3A)2 0.92 2.05 166 2.956(3)
N(2)–H(2N)…O(1)3 0.92 1.99 169 2.903(2)
N(1A)–H(1NA)…N(3)4 0.80 2.15 172 2.943(3)
N(2A)–H(2NA)…O(1A)2 0.91 2.03 153 2.864(2)
N(3A)–H(3NC)…O(1)5 0.85 2.24 168 3.074(3)
Fig. 2  Graph sets and a model to describe the hydrogen-bonded clus-
ter in compound 2
Fig. 3  The asymmetric unit is composed of two independent mol-
ecules
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where, n is the number of compounds, r is the correlation 
coefficient, R2 is the determination coefficient of regression, 
Sreg is the standard deviation of regression and Fstatistic is the 
(2)
log(1/IC50) = +125.038QN(α) + 0.893QN(β) + 96.777PN–H(α)
+ 10.301PN–H(β) − 29.318EHOMO + 115.504ELUMO
+ 12.042ω − 1.345µ+ 2.122 logP − 23.942
n = 11;R2 = 0.828; Sreg = 0.291;
r = 0.530;Fstatistic = 1.203
Fisher’s statistic [27]. The high determination coefficient 
(R2 = 0.828) and low residuals (Sreg = 11.320) are signifi-
cant. High variance inflation factor (VIF >10) (Table 6) are 
associated with the multicollinearity problem. Therefore, 
the variables with a high VIF are candidates for exclusion 
from the model. The improvement in Eq. (2) was carried 
out by omitting compound 4 as outland data from the tested 
compounds and replacing ω with ELUMO as well as PN–H(α) 
with QN(α). Multiple regression performed using the remain-
ing seven parameters yielded the following model with 
Table 4  experimental 
anti-AChE and urease activitis 













No. PAH analogous Biological activity 
IC50 (mM)
References
R1 R2 R3 X AChE Urease
1 (C6H5O) (C6H5O) H O 7.006 3.087
a
2 (C6H5O) (C6H5–NH) H O – –
a
3 (Cl–C6H4O) NH–NH2 H O 8.690 2.213
a
4 (CH3–C6H4O) NH–NH2 H O 5.157 50.037
a
5 (C6H5O) Cl C(O)NH2 O 9.886 7.251
a
6 (Cl–C6H4O) Cl C(O)NH2 O 2.831 4.745
a
7 (C6H5) Cl C(O)NH2 O 5.370 2.364
a
8 (C6H5O) (C6H5O) C(O)NH2 O 4.020 4.137 [27]
9 (C2H5O) (C2H5O) C(O)NH2 O 7.130 1.208 [27]
10 (C2H5O) (C2H5O) C(O)NH2 S 7.140 2.210 [27]
11 (CH3O) (CH3O) C(O)NH2 S 2.340 1.611 [27]
12 (C2H5O) (C2H5O) C(S)NH2 S 35.52 94.843 [27]
13 (CH3–C6H4O) NH–NH–C(O)NH2 C(O)NH2 O – 2.544
a
14 (C2H5O) (C2H5O) P(S)(C2H5O)2 S – 2.623
a
15 (Cl–C6H4O) NH–NH–C6H5 NH–NH–C6H5 O – –
a
16 (CH3–C6H4O) NH–NH–C6H5 NH–NH–C6H5 O – –
a
17 (C2H5O) (C2H5O) NH–NH–C6H5 S – –
a
Table 5  Quantum-chemical and theoretical descriptors for compounds computed at B3LYP/6–311+G** level
No. Electronic Hydroph. Steric
QP QN(α) QN(β) PP=X PN–H(α) PN–H(β) EHOMO ELUMO ω μ logP Mv
1 2.359 −0.829 −0.672 −3.455 1.228 1.239 −0.244 −0.019 0.077 6.886 0.04 126.643
3 2.456 −0.887 −0.745 −3.570 1.314 1.152 −0.235 −0.007 0.064 7.521 −0.16 182.634
4 2.452 −0.837 −0.656 −3.535 1.246 1.020 −0.247 −0.014 0.073 8.989 1.71 189.315
5 2.165 −0.812 −0.495 −3.215 1.268 0.903 −0.268 −0.039 0.103 8.146 0.19 150.991
6 2.162 −0.812 0.408 −3.210 1.238 0.904 −0.263 −0.044 0.108 6.926 1.03 179.817
7 1.985 −0.823 −0.496 −3.050 1.246 0.899 −0.280 −0.059 0.131 3.093 −0.26 171.836
8 2.440 −0.800 −0.485 −3.483 1.214 0.864 −0.246 −0.028 0.086 7.067 1.37 245.822
9 2.447 −0.808 −0.485 −3.512 1.221 0.864 −0.270 −0.022 0.086 7.169 0.89 163.656
10 1.963 −0.797 −0.486 −2.562 1.208 0.868 −0.231 −0.022 0.076 7.246 1.25 161.607
11 1.953 −0.797 −0.486 −2.546 1.209 0.868 −0.234 −0.022 0.077 7.007 1.35 127.581
12 1.974 −0.798 −0.450 −2.616 1.222 0.862 −0.238 −0.031 0.087 9.156 2.15 182.117
14 2.054 −0.855 −0.861 −2.726 1.310 1.305 −0.248 0.029 0.043 9.703 1.84 194.763
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increasing of R2 = 0.822 and decreasing of Sreg = 0.292 
(Eq. 3).
The correlating parameters have VIF <10, thus there 
is no colinearity problem (Table 6). In this equation, the 
inhibitory potency of AChE is influenced mainly by the 
electronic parameters (as frontier molecular orbital ener-
gies). ELUMO with the coefficient value of +47.292 has the 
highest contribution to log(1/IC50) rather than the structural 
parameters. The positive sings of ELUMO in log(1/IC50) 
disclose that the compound with lower molecular orbital 
(ELUMO) is indicative of higher toxicity against AChE 
enzyme. The correlation matrix was used to determine 
the interrelationship between the independent variables 
(Table 7). Table 7 shows that the majority of regression 
coefficients among; were higher than 0.70, showing that 
they were closely correlated. Therefore, orthogonalization 
of the molecular descriptors was conducted [28]. Orthogo-
nalization of molecular descriptors is undertaken to avoid 
collinearity among variables and model overfitting. The 
high interrelationships were observed between ELUMO and 
(3)
log(1/IC50) = +1.002QN(β) + 20.819PN–H(α) − 1.520PN–H(β)
+ 12.071EHOMO + 47.292ELUMO − 0.383µ+ 0.036 logP − 17.384
n = 10;R2 = 0.822; Sreg = 0.292; r = 0.495;Fstatistic = 1.324
EHOMO (r = +0.692), EHOMO and PN–H(α) (r = −0.670), 
with EHOMO and logP (r = +0.627), respectively.
The effect of hydrophobicity and polarizability in mod-
ulating inhibition activity against AChE enzyme may be 
due to the presence of phosphoryl (Pδ+–Oδ−), carbonyl 
(Cδ+–Oδ−) and amine groups (Hδ+–Nδ−); where permanent 
polarization was seen due to electronegativity difference 
between the atoms.
Urease‑QSAR
Also the interaction of urease as a secondary target was inves-
tigated against the tested compounds (1–17) and the same 
procedures were carried out. The QSAR modification model 
based on anti-urease potency produced the following equation:
As a result, as shown in Table 6, the regression equa-
tion is not favorable with the VIF >10. The improvement 
in Eq. (4) was performed by excluding PN–H(α) and ω. Con-
sequently, a new multiple regression was resulted without 
colinearity (Eq. 5).
The model described by Eq. (5), similar to Eq. (3), 
depicts the share of molecular orbital energy variables in 
the inhibition of urease. The most effective variable in the 
interaction of urease and PAH derivatives was ELUMO with 
the coefficient value of +50.169. The high interrelation-
ship in Table 8 (r = +0.727) between ELUMO descriptors 
and PN–H(β) showed that the properties of derivatives affect 
in the inhibition of urease. It means that polarizability and 
(4)
log(1/IC50) = +12.765QN(α) + 0.678QN(β) + 7.064PN–H(α)
− 1.040PN–H(β) − 28.525EHOMO − 22.165ELUMO
− 77.456ω − 0.418µ− 0.283 logP + 4.668
n = 12;R2 = 0.960; Sreg = 0.237;
r = 0.168;Fstatistic = 5.312
(5)
log(1/IC50) = +7.213QN(α) + 0.694QN(β) − 2.186PN–H(β)
− 3.165EHOMO + 50.169ELUMO − 0.263µ
− 0.576 logP + 10.652
n = 12;R2 = 0.947; Sreg = 0.193;
r = 0.020;Fstatistic = 10.179
Table 6  VIFa values of theoretical QSAR equations
a VIF = 1/(1 − Ri2); where, Ri is the multiple correlation coefficient 





Equation (2) Equation (3) Equation (4) Equation (5)
QN(α) 372.737 134.265 3.438
QN(β) 1.820 1.827 1.996 1.891
PN–H(α) 318.146 2.823 269.233
PN–H(β) 67.465 4.655 71.560 4.668
EHOMO 9.092 7.474 217.570 1.507
ELUMO 69.705 7.836 4.045 7.370
ω 1.010 4.856
μ 121.108 5.432 152.001 3.042
logP 103.360 6.286 109.226 4.045
Table 7  Correlation matrix for 
AChE-QSAR in Eq. (2)
Selected variables QN(β) PN–H(α) PN–H(β) EHOMO ELUMO μ logP
QN(β) 1.000
PN–H(α) 0.076 1.000
PN–H(β) −0.300 0.192 1.000
EHOMO −0.242 −0.670 0.107 1.000
ELUMO −0.451 −0.472 0.325 0.692 1.000
μ −0.081 −0.045 0.033 0.528 0.661 1.000
logP 0.077 −0.482 −0.372 0.647 −0.670 −0.045 1.000
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electrostatic interactions were formed between the N–H 
group were occurred with the side chain of urease enzyme.
Conclusion
New (thio)phosphorhydrazide compounds (1–17) were 
synthesized and characterized by spectroscopy methods. 
The cyclic motifs of compound 2 were further determined 
by X-ray crystallography. The inhibitory potencies of the 
selected compounds against human AChE and urease were 
studied. PCA–QSAR was deduced that the electronic param-
eters are predominated from those related to structural 
parameters. DFT–QSAR models for AChE (R2 = 0.822 
and 1.827 < VIF < 7.836) and for urease (R2 = 0.947 and 
1.507 < VIF < 7.370) models revealed that the descriptors of 
the ELUMO parameter affect on the inhibition mechanism of 
enzymes. The correlation matrix of QSAR models and dock-
ing analysis confirmed that ELUMO variable can control the 
influence of the polarizability properties of N–H functional 
group of PAH derivatives in the inhibition of enzymes.
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